Stay updated on Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added revision v3.4.3 and removed revision v3.4.2 in the record history.
    Difference
    0.1%
    Check dated 2026-03-12T18:38:51.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The new screenshot shows a visual/UI refresh while the version history details remain the same; no substantive changes to study records are evident.
    Difference
    0.1%
    Check dated 2026-02-26T15:22:04.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Record History now includes Revision: v3.4.2 and removes Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T02:19:29.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The history now includes a new revision entry for v3.4.1 and removes v3.4.0, affecting only version-tracking metadata and not study details or user-facing content; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:30:12.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The Study Record Versions page now shows a glossary toggle, uses green and red highlights to denote additions and deletions, and updates the revision label to v3.4.0; capitalization for the No FEAR Act label was adjusted.
    Difference
    0.9%
    Check dated 2026-01-28T19:22:36.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The Record History shows a new revision entry (v3.3.4) and removes the prior revision (v3.3.3). This is a log-level update to the history and does not modify the study data.
    Difference
    0.1%
    Check dated 2026-01-14T04:10:56.000Z thumbnail image

Stay in the know with updates to Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan in HER2 Mutant NSCLC Clinical Trial page.